This audit is for a rheumatology trainee weighing a bank marketed as passRH for the SCE Rheumatology. The honest headline first: as of 21 July 2026, repeated searches did not surface a live, independently verifiable product called "passRH" for the SCE Rheumatology, and no accessible product page, question count or price could be confirmed. If you are using a resource under this name, that does not mean it is not worthwhile — it means the numbers are unverified, and you should confirm the live question count, access period, price and blueprint coverage on its own page before relying on any figure. The good news is that the audit method below is what actually matters, and it applies to any rheumatology SCE bank you are assessing.
Current state: what could and could not be verified (21 July 2026)
| Item | Status on 21 July 2026 |
|---|---|
| Live product page for "passRH" (SCE Rheumatology) | Not independently confirmed via search |
| Question count | Unverified — do not trust any figure you cannot see on the product's own page |
| Access period / price | Unverified — confirm on the product page before purchase |
| AI / adaptive features | Unverified |
| Verifiable SCE Rheumatology specialists (for reference) | StudyPRN (vendor-reported ~850 rheumatology SCE questions, 3-month access from £209, checked 21 July 2026); the British Society for Rheumatology member SCE question bank |
Two practical conclusions follow. First, do not spend money against a name alone — a bank you cannot inspect is a bank you cannot audit. Second, if passRH is a live product you can reach, run every step below against it; if you cannot reach it, apply the same steps to a bank you can, such as a verifiable rheumatology SCE specialist. Either way, the discipline is the same.
Exam anchor: the blueprint your audit runs against
The SCE Rheumatology is two papers of 100 best-of-five questions (200 total), three hours each, computer-based on Surpass, one mark per correct answer, no negative marking. The MRCP(UK)/Federation blueprint (verified 21 July 2026) distributes the 200 marks as follows, and this — not a bank's own chapter list — is the yardstick:
| Blueprint domain | Official questions (of 200) |
|---|---|
| Adult inflammatory arthritis, incl. crystal arthropathies | 70 |
| Adult connective tissue disorders | 60 |
| Adult osteoarthritis / soft tissue / regional / widespread pain | 20 |
| Adult infection, neoplasia and miscellaneous | 15 |
| Adult metabolic and bone disease | 13 |
| Paediatric and adolescent rheumatology | 12 |
| Clinical science and pharmacology | 10 |
Distinguish official requirements from vendor claims throughout: the blueprint above is the official requirement; a bank's marketing ("covers the whole syllabus") is a claim you test against it.
Record the live count — and break it down by domain
Do not accept a headline total. A bank advertising "1,000+ rheumatology questions" tells you nothing about balance. Map its questions to the seven blueprint domains and compute the proportion in each, then compare that profile to the official mark load. A bank that is 60% inflammatory arthritis and 5% connective tissue disease is off-blueprint no matter how large it is, because connective tissue disease alone is 60 of 200 marks. If the product will not let you see a domain breakdown, treat the total as marketing and audit a sample yourself.
Sample the question style
Pull a representative sample and characterise it honestly: is it recall ("which antibody is associated with…") or application ("what is the next best step in this patient")? How long are the stems, and are they integrated vignettes or one-liners? How plausible are the four distractors — close variants that demand discrimination, or padding? How often does an item hinge on image or data interpretation (a radiograph, ultrasound, DXA, or a laboratory trend), and does it test management sequencing rather than a single fact? The SCE rewards application, integration and next-step reasoning; a bank that is predominantly short-stem recall will feel productive and under-prepare you.
Check jurisdiction and recency
Take a stratified sample across domains and test it against current UK guidance and primary sources — NICE, CKS, British Society for Rheumatology guidelines, and the SmPC/eMC for medicines information — recording the date you checked. Rheumatology moves: urate-lowering targets, osteoporosis thresholds and drug-holiday timing, biologic and JAK-inhibitor safety, hydroxychloroquine retinopathy screening and pre-biologic infection screening all change. A bank that predates a guideline shift will teach an outdated monitoring interval or first-line choice with total confidence. If explanations do not cite a dateable source, downgrade your trust and verify the fact yourself.
State the format gap plainly
Be honest about what a standard MCQ bank — any bank, passRH or otherwise — cannot do. It can build and test knowledge of imaging, immunology, classification criteria and biologic monitoring, but it cannot substitute for deliberate practice on real images with clinician feedback, and it cannot reproduce the longitudinal judgement of monitoring a patient on a biologic over months. A best-of-five item can show you a radiograph and ask for the finding; it cannot train the eye through a hundred real films. Expect the bank to cover the knowledge and plan the interpretation practice separately.
Assess duplication and contamination
Large banks recycle concepts. Audit for repeated stems, near-duplicate items and clusters of questions testing the same fact in slightly different words — this inflates the apparent size and, worse, converts your practice into recognition once you have seen the pool twice. If completing the bank starts to feel easy because you remember the items rather than reason them out, its measurement value has expired and your percentage no longer means what you think it does. This is precisely why an unseen second source matters near the exam.
Three mistakes when auditing a rheumatology bank
Most flawed bank choices come from the same three errors, and naming them is the quickest way to avoid them. First, trusting the headline total: a bank advertising a large number of questions can still be badly off-blueprint, and size does nothing to close a coverage gap in connective tissue disease or bone disease — a big bank with the wrong balance leaves exactly the same holes as a small one. Second, confusing familiarity with mastery: your rising accuracy on a bank you have already cycled through is measuring memory of its items, not readiness for unseen ones, so a comfortable percentage late in preparation is often the least trustworthy signal you own. Third, auditing against the bank's own chapter list rather than the official blueprint: if you check coverage against the vendor's contents page, you inherit the vendor's blind spots, whereas checking against the MRCP(UK)/Federation blueprint exposes them. Run every audit against the official 70/60/20/15/13/12/10 distribution, not the marketing.
Best-fit matrix
Decide what the bank is actually good for, rather than treating it as an all-purpose answer:
| Role | Fits if… |
|---|---|
| Foundation building | Explanations are strong and teach reasoning, not just answers |
| First pass | Coverage is broad and roughly blueprint-balanced |
| Second bank | It is genuinely unseen relative to your first, adding volume not duplication |
| Retake resource | It exposes new material you have not already memorised |
| Final simulation | It supports full-length, timed, mixed, unseen blocks |
An unverifiable product cannot be placed in this matrix with confidence — which is itself the finding.
Worked example: seven days around clinical work
If you have a verifiable rheumatology bank in hand, run this loop, using the bank for one job (blueprint-balanced first-pass and gap-finding) and iatroX for a different job (unseen adaptive transfer practice, with no proprietary-algorithm claim):
- Day 1: Map the bank's questions to the seven domains; note where the balance is off-blueprint.
- Day 2: 30 items in your two heaviest domains (arthritis, connective tissue disease); log misses.
- Day 3 (clinical): Retrieval only — review Day 2 misses; no new items.
- Day 4: 30 items in the small domains you would otherwise neglect (bone, paediatric, clinical science).
- Day 5: Verify two guidance-sensitive facts against current UK sources; date the checks.
- Day 6: A 40-item unseen, timed mixed block in iatroX; review every miss once.
- Day 7: Re-test the week's misses (spaced); update your domain quotas from the results.
The point of the split is honesty about what each number means: the bank shows you what you have and have not yet seen, while the unseen iatroX block shows you whether that knowledge transfers to a fresh stem. Neither figure means much on its own, but read together they tell you where the next hour of study should go — which is the only thing an audit is really for.
Decision checklist: continue, supplement, switch or stop
Continue a bank only once you have verified it exists, inspected its domain balance and judged its style blueprint-appropriate. Supplement it with an unseen-measurement source and dedicated image practice, which no single bank supplies. Switch away from any product you cannot verify or that is off-blueprint, too easy, or out of date. Stop relying on a bank the moment completion has become recognition. Every decision rests on a measured property of the bank — coverage, style, recency, duplication — not on its name or your sunk cost.
FAQ
Is passRH enough for SCE Rheumatology on its own? It cannot be judged sufficient, because as of 21 July 2026 the product could not be independently verified, and an unverifiable bank is one you cannot audit for coverage, recency or duplication. As a general principle, no single bank is enough for the SCE Rheumatology: you need blueprint-balanced coverage, an unseen source for timed mixed blocks, and separate image and monitoring practice. Confirm any product's live details on its own page before committing.
Which SCE Rheumatology component does passRH not reproduce well? Whatever its content, a standard MCQ bank does not reproduce deliberate image interpretation on real films or the longitudinal judgement of biologic monitoring — those need clinician-supervised practice, not stems. It also cannot provide an unseen readiness signal once you have cycled through its pool. Plan image work and an unseen-measurement source separately, and do not expect a single bank to cover them.
How many passRH questions should I complete per day for SCE Rheumatology? No daily figure can be given, because the product's live question count is unverified. As general guidance, aim for a sustainable number of fully reviewed unseen items — often 30–40 on a study day around clinical work — weighted toward the heavy blueprint domains, with misses re-tested after a spacing gap. Volume without review is the least productive way to spend the time.
When should I stop using passRH and move to mixed mocks? Move to full-length, timed, mixed mocks once coverage across the seven domains is adequate, your accuracy on unseen items has plateaued, and your recency checks are done — and stop using any single-topic drilling that has become recognition rather than reasoning. Ring-fence unseen mixed blocks for the final weeks so they still measure something. If the product is unverifiable, run the mocks in a source you can actually access.
How should I combine passRH with iatroX without duplicating practice? Give them separate jobs and never share items: use the verified bank for blueprint-balanced first-pass practice, and use iatroX for unseen, timed mixed blocks and spaced retrieval of your errors. The second resource is valuable precisely because it is unseen — that is the two-Q-bank rule. iatroX is not a rheumatology-specific bank; treat it as the cross-specialty knowledge and measurement layer alongside your specialty material.
Editorial notes and references
Written by Dr Kolawole Tytler, NHS GP and founder of iatroX. Last checked 21 July 2026. Honesty flag: a live, independently verifiable product called "passRH" for the SCE Rheumatology could not be confirmed on 21 July 2026; all product figures are therefore unverified and must be checked on the product's own page. Verifiable comparators cited (StudyPRN ~850 rheumatology SCE questions, 3-month access from £209; the BSR member SCE question bank) are vendor/society-reported and dated 21 July 2026. Exam-format and blueprint figures are from the Federation of the Royal Colleges of Physicians of the UK; the blueprint counts are quoted from the published SCE Rheumatology blueprint, which notes the count may vary slightly per diet. Medicines facts should come from the SmPC/eMC and current BSR/NICE guidance. Disclosure: iatroX operates a competing question-bank and knowledge platform; it is not a rheumatology-specific SCE bank, and its role here is confined to the cross-specialty knowledge, spaced-retrieval and unseen-measurement layer. Corrections are welcome via the feedback route on iatrox.com. References: the Federation SCE Rheumatology page and blueprint (thefederation.uk); StudyPRN rheumatology SCE page (studyprn.com); BSR SCE pages (rheumatology.org.uk); the SCE Rheumatology content-gap checklist (iatroX); and Your Q-Bank Percentage Is Not Your Exam Score.